ALPH — AlphaHelix Molecular Diagnostics AB (publ) Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Market Cap
SEK19.02m
Enterprise Value
SEK16.50m
Revenue
SEK26.67m

Annual income statement for AlphaHelix Molecular Diagnostics AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	R2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Interim Report	ARS	ARS	PRESS	ARS
Standards:	—	SAS	SAS	—	SAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	17.2	23.7	44.7	34.7	26.7
Cost of Revenue
Gross Profit	—	9.32	18.6	—	12.8
Selling / General / Administrative Expenses
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	18.1	22.2	39.4	37	36.4
Operating Profit	-0.874	1.55	5.26	-2.33	-9.73
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-0.973	1.52	5.21	-2.41	-9.69
Provision for Income Taxes
Net Income After Taxes	-0.984	1.51	5.16	-2.22	-9.48
Net Income Before Extraordinary Items
Net Income	-0.984	1.51	5.16	-2.22	-9.48
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-0.983	1.51	5.16	-2.22	-9.48
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.019	0.029	0.089	-0.035	-0.149
Dividends per Share